LDL/HDL Ratio in Women: From the Pill to After Menopause

The numerator of this number is your LDL cholesterol, the denominator your HDL cholesterol. No separate tube of blood is drawn for it: the laboratory divides two values that were already on your report and prints the outcome as a single dimensionless figure. What makes this fraction distinctive in women sits not in the numerator but in the denominator.

Oestrogen stimulates the production of HDL particles. Women in their reproductive years therefore carry a markedly higher HDL on average than men of the same age, and a larger denominator makes every fraction smaller. At an identical LDL your outcome lands lower than your partner's, without anything having been said about your artery wall. Work it through: an LDL of 3.6 mmol/l alongside an HDL of 1.8 mmol/l gives a tidy 2.0, while the very same LDL alongside an HDL of 1.1 mmol/l lands at 3.3. One numerator, two entirely different conclusions.

That numerator is meanwhile the most fragile part of the sum. In most laboratories your LDL is not measured but estimated: total cholesterol, reduced by the HDL and by a fixed share of the triglycerides. The estimate assumes triglycerides stay modest. Take an oestrogen preparation by mouth and they climb instead, so the estimated LDL drops away when it should not. The cholesterol/HDL ratio does not carry that flaw, because both of its values are determined directly.

Do not confuse the two, incidentally. The cholesterol/HDL ratio puts total cholesterol above the line and moves around an upper limit of 5. This one puts only the LDL there and works with 3. Anyone laying one limit over the other result misreads their own blood every single time.

A single cut-off for both sexes sounds even-handed, but it lands unevenly. Because women's HDL sits higher on average, the 3.0 limit is in practice a far gentler test for you than for a man. You can sit comfortably below 3.0 with an LDL your own doctor would want to raise with you. That is the heart of the objection to this number in women's medicine: it reassures at exactly the moment there is something to discuss.

On top of that comes the arithmetic blindness of any fraction. Take two women who both land on 3.0. The first has 3.0 mmol/l LDL alongside 1.0 mmol/l HDL. The second has 4.5 mmol/l LDL alongside 1.5 mmol/l HDL. Their figure is identical, yet the second carries half as much harmful cholesterol again. It is that absolute quantity which settles into the artery wall across decades, not the division.

Then the transition. In the years around menopause you lose the oestrogenic protection from two sides at once: LDL climbs while HDL often slips a little. With almost any other cause only one half of the fraction moves; here they move together. The consequence is that the ratio rises more steeply than the LDL or the HDL on their own, and a woman used to years of favourable results can end up on the wrong side of the line within a few years. That is not a personal failure and it is certainly not a diagnosis; it is a hormonal shift becoming visible in your lipids.

And then this: no guideline sets a target for this fraction. The European ESC/EAS guideline and the Dutch CVRM standard steer on the LDL itself, with non-HDL cholesterol and ApoB as secondary goals. If either of those appears on your report, let it weigh more heavily than any fraction. Non-HDL also counts the VLDL and remnant particles that are entirely absent from this ratio, and ApoB counts the number of harmful particles rather than their cargo. Both tell you something this division cannot.

You do not order this ratio separately; it arrives automatically as soon as a lipid panel has determined the LDL and the HDL. So the question is when such a panel yields anything meaningful, and in women that depends more on life stage than on age.

Your cycle is not a serious obstacle here: cholesterol values drift slightly with it, but not enough to overturn a result. Hormone use counts for far more. Starting or stopping the pill, switching to another preparation, or beginning hormone therapy around menopause changes your profile within a few months. So do not test in the first weeks afterwards, and record with every result which preparation you were using at the time.

Fasting weighs more heavily here than for the individual cholesterol values, because your LDL is derived from the triglycerides. Above roughly 4.5 mmol/l that derivation is no longer valid and the outcome says nothing. Pregnancy also lifts the whole lipid profile substantially; a panel belongs some months after delivery, not before. Wait a few weeks after an infection or surgery as well, and when comparing two results allow for the natural noise of five to ten percent on the LDL.

A newly unfavourable profile deserves an explanation before your diet takes the blame. An underactive thyroid raises LDL and occurs considerably more often in women than in men, so a TSH belongs in the first round. Poorly controlled diabetes, kidney and liver disease, heavy alcohol use and a range of medicines can equally explain the picture.

The table below gives the direction per life stage, not a cut-off per group.

Always have your result assessed by a doctor, together with your individual values and your full risk profile.